Adding PharmaCyte Biotech (PMCB) to the Portfolio Might Be a Good Move
By: Mark Leibovit
Adding PMCB (PharmaCyte Biotech) to the portfolio with a .10 mental stop and a .20-.25 upside trading objective.
PharmaCyte Biotech, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology, known as Cell-in-a-Box. Its patented Cell-in-a-Box technology would be used as a platform to built treatments for various types of cancer, including advanced, inoperable pancreatic cancer and diabetes. The company is also working towards enhancing the quality of life for patients with advanced pancreatic cancer and on treatments for other types of abdominal cancers using the Cell-in-a-Box technology. PharmaCyte Biotech is preparing for a Phase 2b clinical trial with its pancreatic cancer treatment in patients with advanced, inoperable pancreatic cancer in Australia; and preclinical studies and clinical trials of that same pancreatic cancer treatment to study its effects on major symptoms associated with pancreatic cancer. Its treatment for pancreatic cancer involves low doses of the anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or ‘cancer-killing’ form. These capsules are placed as close to the cancerous tumor as possible to enable the delivery of the cancer-killing drug at the source of the cancer. In addition, the company is developing treatments for cancer based upon chemical constituents of the Cannabis plant, known as cannabinoids. PharmaCyte Biotech is examining ways to exploit the benefits of Cell-in-a-Box technology in optimizing the anticancer effectiveness of cannabinoids. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was founded in 1996 and is based in Silver Spring, Maryland.
Any thoughts on PharmaCyte Biotech? Share your thoughts below and subscribe to WeedTV.com HERE